Literature DB >> 2540262

Does the PCPA induced anticonflict effect involve activation of the GABAA/benzodiazepine chloride ionophore receptor complex?

B Söderpalm1, J A Engel.   

Abstract

The effects of the benzodiazepine (BDZ) receptor antagonist flumazenil (Ro 15-1788) and the GABAA receptor antagonist bicuculline on the anticonflict effect observed after depletion of brain serotonin (5-HT), were examined in a modified Vogel's punished drinking conflict model. Pretreatment with para-chlorophenylalanine (PCPA; 300 mg/kg/day for three days, last injection - 24 h) markedly decreased brain 5-HT levels and produced clearcut anticonflict effects. The anticonflict effect, but not the biochemical effect, of PCPA pretreatment was completely counteracted by both flumazenil (10 mg/kg, - 30 min) and bicuculline (2.0 mg/kg, - 10 min), in doses not altering the behavior per se. The findings suggest a behavioral interaction between 5-HT systems and the GABAA/BDZ chloride ionophore receptor complex, possibly involving a direct neuronal interaction, neuromodulation or hormonal alterations.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2540262     DOI: 10.1007/bf01578754

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  20 in total

1.  Effects of amperozide in two animal models of anxiety.

Authors:  J A Engel; P Egbe; S Liljequist; B Söderpalm
Journal:  Pharmacol Toxicol       Date:  1989-05

2.  Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor.

Authors:  M D Majewska; N L Harrison; R D Schwartz; J L Barker; S M Paul
Journal:  Science       Date:  1986-05-23       Impact factor: 47.728

Review 3.  Serotonin and anxiety revisited.

Authors:  R S Kahn; H M van Praag; S Wetzler; G M Asnis; G Barr
Journal:  Biol Psychiatry       Date:  1988-01-15       Impact factor: 13.382

4.  p-Chlorophenylalanine: a specific depletor of brain serotonin.

Authors:  B K Koe; A Weissman
Journal:  J Pharmacol Exp Ther       Date:  1966-12       Impact factor: 4.030

5.  Interaction of serotonin with somatosensory cortical neuronal responses to afferent synaptic inputs and putative neurotransmitters.

Authors:  B D Waterhouse; H C Moises; D J Woodward
Journal:  Brain Res Bull       Date:  1986-10       Impact factor: 4.077

6.  Alpha 2-adrenoceptor antagonists potentiate the anticonflict and the rotarod impairing effects of benzodiazepines.

Authors:  B Söderpalm; J A Engel
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

7.  Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).

Authors:  J A Engel; S Hjorth; K Svensson; A Carlsson; S Liljequist
Journal:  Eur J Pharmacol       Date:  1984-10-15       Impact factor: 4.432

8.  Gepirone in anxiety: a pilot study.

Authors:  I Csanalosi; E Schweizer; W G Case; K Rickels
Journal:  J Clin Psychopharmacol       Date:  1987-02       Impact factor: 3.153

9.  Are serotonergic neurons involved in the control of anxiety and in the anxiolytic activity of benzodiazepines?

Authors:  M H Thiebot
Journal:  Pharmacol Biochem Behav       Date:  1986-05       Impact factor: 3.533

10.  Selective antagonists of benzodiazepines.

Authors:  W Hunkeler; H Möhler; L Pieri; P Polc; E P Bonetti; R Cumin; R Schaffner; W Haefely
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

View more
  3 in total

1.  Pharmacological profile of a potential anxiolytic: AP159, a new benzothieno-pyridine derivative.

Authors:  T Nagatani; T Yamamoto; K Takao; S Hashimoto; K Kasahara; T Sugihara; S Ueki
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  The yohimbine-induced anticonflict effect in the rat, Part I. Involvement of noradrenergic, serotonergic and endozepinergic(?) mechanisms.

Authors:  A Söderpalm; O Blomqvist; B Söderpalm
Journal:  J Neural Transm Gen Sect       Date:  1995

3.  Anxiolytic effect of serotonin depletion in the novelty-induced hypophagia test.

Authors:  Anita J Bechtholt; Tiffany E Hill; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2006-12-13       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.